---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-110168"
form_type: "8-K"
ticker: "BTSG"
cik: "0001865782"
company_name: "BrightSpring Health Services, Inc."
filed_at: "2024-09-30T23:59:59+00:00"
generated_at: "2026-05-31T00:54:13.347621+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# BrightSpring Health Services appoints Dr. Steve Miller to Board of Directors

## Summary
- Dr. Steve Miller appointed as Class II director on September 27, 2024; board expands from 7 to 8 members.
- Miller will serve on Audit Committee and chair Quality & Compliance and Governance Committee.
- Former Chief Clinical Officer of Cigna (2018-2022) and CMO of Express Scripts (2005-2018).
- No transactions requiring disclosure under Item 404(a) between Miller and the company.

## SEC filing metadata
- accession: 0000950170-24-110168
- form_type: 8-K
- ticker: BTSG
- cik: 0001865782
- company_name: BrightSpring Health Services, Inc.
- filed_at: 2024-09-30T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1865782/000095017024110168/0000950170-24-110168-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1865782/000095017024110168/btsg-20240927.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-110168
- JSON: https://secwatch.observer/filing/0000950170-24-110168.json
- Plain text: https://secwatch.observer/filing/0000950170-24-110168.txt

## Key facts
- Executive change
  Dr. Steve Miller was appointed as Class II director at BrightSpring Health Services, Inc..
  - Action: appointed
  - Role: Class II director
  source text: On September 27, 2024, the board of directors (the “Board”) of BrightSpring Health Services, Inc. (the “Company”) increased the number of directors serving on the Board from seven (7) to eight (8) members and appointed Dr. Steve Miller to the Board as a Class II director to fill the resulting vacancy.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1865782/000095017024110168/0000950170-24-110168-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.